Computational pathology-informed immune biomarker for trastuzumab benefit in HER2+ breast cancer: Validation in NSABP B-41 clinical trial.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Topic: AI in cancer detection
Subfield: Artificial Intelligence
Field: Computer Science
Domain: Physical Sciences
Open Access status: closed
Funder: National Institutes of Health
Award: G9000029644
OpenAlex ID: W4410809141
